Sevoflurane reduces synaptic glutamate release in human synaptosomes

Area of Science:

• Neuroscience
• Anesthesiology
• Synaptic Transmission

Background:

• Volatile anesthetics are known to decrease excitatory synaptic transmission in the brain.
• Understanding the precise mechanisms of anesthetic action on neurotransmitter release is crucial for clinical practice.

Purpose of the Study:

• To investigate the effects of sevoflurane on glutamate release, intracellular calcium levels ([Ca2+]i), and glutamate uptake in isolated human cerebral cortex presynaptic terminals.
• To elucidate the impact of sevoflurane on key components of excitatory synaptic function.

Main Methods:

• Isolated presynaptic terminals from human temporal lobe epilepsy specimens were utilized.
• Glutamate release and [Ca2+]i were measured using fluorescence techniques (NADPH and fura-2).
• Glutamate uptake was quantified using radiolabeled glutamate and a beta-scintillation counter.

Main Results:

• Sevoflurane (2.5% and 4.0%) significantly attenuated Ca2+-dependent glutamate release by 45% and 55%, respectively.
• The anesthetic agent did not significantly alter the evoked increase in [Ca2+]i.
• Sevoflurane (2.5%) did not significantly affect the kinetic parameters (Km and Vmax) of high-affinity glutamate uptake.

Conclusions:

• Sevoflurane reduces Ca2+-dependent glutamate release in the human brain.
• The findings suggest that sevoflurane's primary effect on excitatory transmission involves modulating presynaptic glutamate release, rather than altering intracellular calcium dynamics or glutamate transport.
• Further research is needed to fully resolve the exact mode of action of sevoflurane on synaptic transmission.